Novel anti-clotting therapy in halted trial no better than existing agents

16 marzo 2015

A novel therapy that would allow doctors to turn the body’s blood-clotting ability off and on in a more controlled way was about as effective as established anticoagulants in patients undergoing angioplasty but was associated with higher rates of moderate to severe bleeding, according to an analysis of data from a terminated Phase III trial.